Quantamental Technologies LLC Blueprint Medicines Corp Transaction History

Quantamental Technologies LLC

  • $105 Million
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$92.08 - $124.48 $423,936 - $573,105
-4,604 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$66.45 - $92.7 $113,230 - $157,960
1,704 Added 58.76%
4,604 $427,000
Q2 2020

Aug 14, 2020
BUY
$57.09 - $79.27 $165,561 - $229,883
2,900 New
2,900 $226,000

Others Institutions Holding BPMC

# of Institutions
313
Shares Held
60.6M
Call Options Held
634K
Put Options Held
691K
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $6.51B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email